A Rubella pandemic has continued in
In February 2013, a 25-year-old man who had generalized seizure with fever and rash was diagnosed with rubella encephalitis by the detection of rubella virus from throat swab and seroconversion of IgM antibodies at the
Moreover, in the 10th week of 2013, a second case of congenital rubella syndrome (CRS) was reported from Aichi prefecture which is located around the middle of
Generally, rubella is [more common] in the spring to summer. So the number of patients in the future likely will continue to increase. The Tokyo Prefectural Government on 14 Mar 2013 decided to pay a part of the cost of rubella vaccination in adults aged over 19 years old as emergent preventive measures against this epidemic. Urgent vaccinations against rubella needs to be promoted for all of people who have never had rubella before and have not been immunized against it.
As a result of the circumstance that in
Rubella is an acute, contagious viral infection. While the illness is generally mild in children, it has serious consequences in pregnant women, causing fetal death or congenital defects known as congenital rubella syndrome (CRS). When an adult woman is infected with rubella virus early in pregnancy, she has a 90 percent chance of passing the virus on to her fetus. This can cause miscarriage, stillbirth, or severe birth defects known as CRS. Infants with CRS may excrete the virus for a year or more. Children with CRS can suffer hearing impairments, eye and heart defects, and other lifelong disabilities, including autism, diabetes mellitus, and thyroid dysfunction, many of which require costly therapy, surgeries, and other expensive care.
Rubella vaccine is normally included as a component of the MMR (measles, mumps, rubella) triple vaccine administered in early childhood. The rubella component of the MMR triple childhood vaccine is a live [naturally] attenuated strain that has been in use for more than 40 years. A single dose gives more than 95 percent long-lasting immunity, which is similar to that induced by natural infection. The reason for the past policy in
Communicated by: ProMed mail
Phone: +27 (011) 025 3297
Fax: +27 087 9411350 / 1
Postal address: SASTM, PO Box 8216, Greenstone, 1616, South Africa
Physical address: SASTM, 27 Linksfield Road Block 2 a Dunvegan Edenvale
Registered as a Nonprofit Organisation 063-296-NPO
The content and opinions are neither pre-screened nor endorsed by the SASTM. The content should neither be interpreted nor quoted as inherently accurate or authoritative.
The information provided in SASTM Newsflashes is collected from various news sources, health agencies and government agencies. Although the information is believed to be accurate, any express or implied warranty as to its suitability for any purpose is categorically disclaimed. In particular, this information should not be construed to serve as medical advice for any individual. The health information provided is general in nature, and may not be appropriate for all persons. Medical advice may vary because of individual differences in such factors as health risks, current medical conditions and treatment, allergies, pregnancy and breast feeding, etc. In addition, global health risks are constantly evolving and changing. International travelers should consult a qualified physician for medical advice prior to departure.